Entering text into the input field will update the search result below

Syndax Pharmaceuticals, Inc. (SNDX) CEO Dr. Briggs Morrison on Q4 2020 Results - Earnings Call Transcript

Mar. 08, 2021 9:00 PM ETSyndax Pharmaceuticals, Inc. (SNDX)
SA Transcripts profile picture
SA Transcripts

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2020 Results Conference Call March 8, 2021 4:30 PM ET

Company Participants

Maghan Meyers - Argot Partners

Dr. Briggs Morrison - Chief Executive Officer

Daphne Karydas - Chief Financial Officer

Michael Metzger - President, Chief Operating Officer

Dr. Michael Meyers - Chief Medical Officer

Dr. Peter Ordentlich - Chief Scientific Officer

Conference Call Participants

Philip Nadeau - Cowen & Company

Bert Hazlett - BTIG

Konstantinos Aprilakis - Stifel

David Lebowitz - Morgan Stanley

Justin Walsh - B. Riley Securities

Peter Lawson - Barclays


Good day, everyone, and welcome to the Syndax Fourth Quarter and Full Year 2020 Earnings Conference Call. Today's call is being recorded.

At this time, I would like to turn the call over to Ms. Maghan Meyers of Argot Partners. Please begin.

Maghan Meyers

Welcome, and thank you to those of you joining us on the line and the webcast this afternoon for a review of Syndax' fourth quarter 2020 financial and operating results. I'm Maghan Meyers with Argot Partners. And with me this afternoon to discuss the results and provide an update on the Company's progress are Dr. Briggs Morrison, Chief Executive Officer; Daphne Karydas, Chief Financial Officer; also joining us on the call today for the question-and-answer session is Michael Metzger, President and COO; Dr. Michael Meyers, Chief Medical Officer; and Dr. Peter Ordentlich, Chief Scientific Officer.

This call is being accompanied by a slide deck that has been posted to the Company's website, so I would ask you to please turn to our forward-looking statements on Slide 2. Before we begin, I would like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Actual results

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.